These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23050789)

  • 41. Temporal trends and clinical correlates for the ret/PTC1 mutation in papillary thyroid carcinoma.
    Burgess JR; Skabo S; McArdle K; Tucker P
    ANZ J Surg; 2003; 73(1-2):31-5. PubMed ID: 12534735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.
    Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA
    Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer.
    Park G; Kim TH; Lee HO; Lim JA; Won JK; Min HS; Lee KE; Park DJ; Park YJ; Park WY
    Endocr Relat Cancer; 2015 Feb; 22(1):55-63. PubMed ID: 25527510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The correlation between BRAF mutations, RET/PTC rearrangements and platelet-derived growth factor B expression in papillary thyroid carcinomas].
    Wang P; Wang YG; Zhao WJ; Fu YD; Wang L; Wang F; Zhao SH
    Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):987-91. PubMed ID: 23327964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
    Vanden Borre P; Schrock AB; Anderson PM; Morris JC; Heilmann AM; Holmes O; Wang K; Johnson A; Waguespack SG; Ou SI; Khan S; Fung KM; Stephens PJ; Erlich RL; Miller VA; Ross JS; Ali SM
    Oncologist; 2017 Mar; 22(3):255-263. PubMed ID: 28209747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.
    Xu X; Quiros RM; Gattuso P; Ain KB; Prinz RA
    Cancer Res; 2003 Aug; 63(15):4561-7. PubMed ID: 12907632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).
    Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas.
    Puxeddu E; Moretti S; Giannico A; Martinelli M; Marino C; Avenia N; Cristofani R; Farabi R; Reboldi G; Ribacchi R; Pontecorvi A; Santeusanio F
    Eur J Endocrinol; 2003 May; 148(5):505-13. PubMed ID: 12720532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational and clinico-pathological analysis of papillary thyroid carcinoma in Serbia.
    Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Pupic G; Zivkovic O; Markovic I; Djurisic I; Buta M; Dimitrijevic B; Rogounovitch T; Mitsutake N; Mine M; Shibata Y; Nakashima M; Yamashita S
    Endocr J; 2011; 58(5):381-93. PubMed ID: 21498916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.
    Henderson YC; Shellenberger TD; Williams MD; El-Naggar AK; Fredrick MJ; Cieply KM; Clayman GL
    Clin Cancer Res; 2009 Jan; 15(2):485-91. PubMed ID: 19147753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.
    Nikiforova MN; Ciampi R; Salvatore G; Santoro M; Gandhi M; Knauf JA; Thomas GA; Jeremiah S; Bogdanova TI; Tronko MD; Fagin JA; Nikiforov YE
    Cancer Lett; 2004 Jun; 209(1):1-6. PubMed ID: 15145515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Rearrangement of the RET gene in papillary thyroid carcinoma].
    Wiench M; Włoch J; Oczko M; Gubała E; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():64-71. PubMed ID: 12182064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
    Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
    Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement.
    Pizzolanti G; Russo L; Richiusa P; Bronte V; Nuara RB; Rodolico V; Amato MC; Smeraldi L; Sisto PS; Nucera M; Bommarito A; Citarrella R; Lo Coco R; Cabibi D; Lo Coco A; Frasca F; Gulotta G; Latteri MA; Modica G; Galluzzo A; Giordano C
    Thyroid; 2007 Nov; 17(11):1109-15. PubMed ID: 17727338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ret rearrangements in Japanese pediatric and adult papillary thyroid cancers.
    Motomura T; Nikiforov YE; Namba H; Ashizawa K; Nagataki S; Yamashita S; Fagin JA
    Thyroid; 1998 Jun; 8(6):485-9. PubMed ID: 9669285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.
    Caria P; Cantara S; Frau DV; Pacini F; Vanni R; Dettori T
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.
    Sadow PM; Heinrich MC; Corless CL; Fletcher JA; Nosé V
    Endocr Pathol; 2010 Jun; 21(2):73-9. PubMed ID: 20012784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.
    Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM
    Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.
    Ferraz C; Rehfeld C; Krogdahl A; Precht Jensen EM; Bösenberg E; Narz F; Hegedüs L; Paschke R; Eszlinger M
    Thyroid; 2012 Oct; 22(10):1025-30. PubMed ID: 23025542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.